Heart Failure: Medication Management

Course overview

More than 6 million people in the U.S. over the age of 20 had heart failure (HF) between 2013 and 2016 (Virani et al., 2020). HF has a major economic impact in the U.S. In 2012, the total cost was $30.7 billion, including medication costs, time spent in hospitals, and missed workdays (CDC, 2020). HF costs are projected to double to more than $69.7 billion by 2030 (Benjamin et al., 2017). Due to the complexity and progression of HF, healthcare providers (HCPs) should be aware of the appropriate long-term management goals of HF that may improve disease progression, including morbidity and mortality.